93
Participants
Start Date
July 31, 2008
Primary Completion Date
February 28, 2009
Study Completion Date
February 28, 2009
Saxagliptin
Tablets, Oral, 5mg, once daily, 4 weeks
Placebo
Tablets, Oral, 0 mg, once daily, 4 weeks
Local Institution, Marikina City
Local Institution, Cebu City
Clinilabs, Inc., New York
Local Institution, Milan
Local Institution, Aguascalientes
Endocrine Research Solutions, Inc., Roswell
River Birch Research Alliance, Llc, Blue Ridge
Local Institution, Kfar Saba
Jasper Clinic, Inc., Kalamazoo
Local Institution, Holon
Local Institution, Monterrey
Local Institution, Ẕerifin
Dgd Research, Inc., San Antonio
Avastra Clinical Trials, Midvale
Dedicated Phase I, Inc., Phoenix
Local Institution, Jerusalem
Amcr Institute, Inc, Escondido
Pacific Sleep Medicine Services (Avastra Clinical Trials), Redlands
Irvine Center For Clinical Research, Inc., Irvine
Advantage Clinical Research, Santa Ana
Orange County Research Center, Tustin
Covance Cru, Inc., Portland
Local Institution, Martínez
Local Institution, Ponce
Local Institution, Lund
Local Institution, Gothenburg
Local Institution, Huddinge
Lead Sponsor
AstraZeneca
INDUSTRY